Of interest, Lfd-NPs efficiently reduced serum levels of TNFα, IL-1β, and IL-6 to a negative control level, suggesting the possible efficacy of Lfd-NPs in treating RA-associated inflammation. This evidence concerns the gene IL1B and rheumatoid arthritis.